Sudeep Pharma Limited (BOM:544619)
India · Delayed Price · Currency is INR 1,111.10
-1.50 (-0.13%)
At close: Aug 21, 2026
Sudeep Pharma Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Sudeep Pharma stock has a consensus rating of "Sell" and an average price target of ₹777.50. The average 1-year stock price forecast is 30.02% lower than the current stock price, while the lowest is ₹700.00 (-37.00%) and the highest is ₹855.00 (-23.05%).
Price Target: ₹777.50 (-30.02%)
Analyst Consensus: Sell
Price Target
ChartAnalyst Ratings
The average analyst rating for Sudeep Pharma stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Feb '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 0 | 0 | 0 |
| Hold | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 1 |
| Total | 1 | 2 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
7.28B
from 6.42B
Increased by 13.29%
Revenue Next Year
9.38B
from 7.28B
Increased by 28.92%
EPS This Year
17.30
from 15.50
Increased by 11.61%
EPS Next Year
19.35
from 17.30
Increased by 11.85%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.